Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

News | Pharmaceuticals

November 15, 2018 — AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes ...

Home November 15, 2018
Home
Russel Pate, Ph.D., Univerity Of South Carolina, chair of the National Physical Activity Plan Alliance. #AHA18
Feature | AHA

November 7, 2018 — Here is a list of some of the key clinical trial presentations at the 2018 American Heart Association ...

Home November 20, 2018
Home
News | Heart Failure

November 6, 2018 – Initial results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) ...

Home November 07, 2018
Home
News | Heart Failure

November 2, 2018 — In a new study, acute heart failure patients who received individualized treatment by blood volume ...

Home November 02, 2018
Home
News | Heart Failure

November 1, 2018 — Daxor Corp. has entered an agreement with CHF Solutions to explore clinical synergies between Daxor’s ...

Home November 01, 2018
Home
News | Heart Failure

October 29, 2018 — The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is ...

Home October 29, 2018
Home
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.
Feature | Heart Failure

October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S ...

Home October 19, 2018
Home
Blog | TCT

From a cardiovascular device innovation standpoint, the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference ...

Home October 15, 2018
Home
Videos

A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston ...

Home October 11, 2018
Home
News | Heart Failure

October 4, 2018 — The Ohio State University Wexner Medical Center is first in the country to test a new medical device ...

Home October 04, 2018
Home
One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon Stertzer, M.D. In this article he shares his views on the current direction and next steps in cardiovascular biomedical technology
Feature

One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon ...

Home October 03, 2018
Home
News | Heart Failure

September 28, 2018 — Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical ...

Home September 28, 2018
Home
Videos | Heart Failure

William Abraham, M.D., FACC, professor of medicine and director of the division of cardiovascular medicine, The Ohio ...

Home September 26, 2018
Home
News | Heart Valve Technology

September 26, 2018 — Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic ...

Home September 26, 2018
Home
Subscribe Now